Compare Gartner Inc (IT) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gartner Inc vs Revvity Inc — how do they compare? Gartner Inc trades at $136.47 (market cap $9.44B), while Revvity Inc trades at $110.1 (market cap $11.87B). The key difference: Revvity Inc is the larger of the two by market cap, and Revvity Inc pays a 0.26% dividend while Gartner Inc pays none. Which is the better fit depends on your goals.
| IT | RVTY | |
|---|---|---|
Market Cap | $9.44B | $11.87B |
Sector | Technology | Technology |
52-Week High | $357.98 | $117.75 |
52-Week Low | $125.68 | $82.26 |
Enterprise Value | $11.04B | $14.36B |
Dividend Yield | — | 0.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gartner (IT) trades at $134.77, down 3.87% today, with a neutral technical signal and bearish moving averages. The stock shows strong profitability with a gross margin of 68.99% and has beaten earnings estimates for three consecutive quarters. Recent news highlights its leadership in Gartner Magic Quadrant reports but also notes an ongoing legal investigation.
The outlook is mixed: analyst consensus targets $157.60 with a buy rating, but net cash flow turned negative in 2025. Key risks include competitive pressures and the legal probe, while valuation metrics like a P/E of 13.94 suggest potential upside if earnings growth resumes.
RVTY trades at $106.44, down 3.37% today, with a bullish technical outlook despite near-term weakness. The company maintains stable revenue around $2.9B with consistent earnings beats, though valuation multiples appear elevated with a P/E of 51. Recent AI product launches and FDA clearances demonstrate innovation in life sciences and diagnostics. Analyst consensus remains positive with a $111.43 price target and no sell ratings among 29 covering firms.
The stock presents a growth opportunity with strong analyst support and technological innovation, but faces risks from margin pressure and China market exposure. Current levels near support at $105 offer potential entry, though the high P/E requires sustained earnings growth to justify valuation. Upcoming Q2 earnings on August 4, 2026 will be critical for near-term direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Gartner Inc
Based in Stamford, Conn., Gartner provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services and hosted nearly 80 IT conferences across the globe in 2007.
Read more on IT →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
